All the major theater chains are now officially begging for the Paramount/Warner Bros. merger
Cinemark, the third major U.S. theater chain, endorsed the $111 billion Paramount/Warner Bros. merger, supporting CEO David Ellison's promise of 30 films annually and a 45-day VOD wait. AMC and Regal previously endorsed the deal. Cinema United, a lobby group, opposes the merger due to antitrust concerns, and the court case is delayed until 2027.
How this was made
The 30-second read
Why it matters
Exhibitor support may reduce regulatory risk and influence stock sentiment for the involved companies.
Market read
The endorsement could smooth the path for a large media consolidation, affecting theater and media stocks.
What to watch
Potential pushback from independent theaters and streaming competitors.
Background
The article reports on theater chains publicly backing the pending Paramount‑Warner Bros. merger.
Ticker impact
Cinemark publicly endorsed the Paramount‑Warner Bros. merger, urging regulators to allow it.
Modest upside for CNK if merger proceeds.
Support from a major exhibitor reduces antitrust concerns.
AMC, another major chain, is mentioned as also supporting the merger.
Potential slight rally on news of industry consensus.
No new statement from AMC itself; only mentioned as a peer.
Warner Bros. Discovery is the target of the merger.
Potential modest gain as merger looks more certain.
Industry backing may smooth antitrust review.
Market effects
The endorsement may ease antitrust concerns for the media consolidation trend.
U.S. theater sector may see short‑term sentiment lift.
The $111 billion deal remains a headline for global media investors.
Counterpoint
Regulators could still block the merger despite exhibitor support.
Key entities
- companyCinemark
Major U.S. theater chain endorsing the merger.
- companyParamount Global
Acquirer in the $111 billion deal.
- companyWarner Bros. Discovery
Target of the merger.





